Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Invested Capital (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Invested Capital for 14 consecutive years, with $18.3 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 267.2% to $18.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, up 267.2% year-over-year, with the annual reading at $18.3 million for FY2025, 267.2% up from the prior year.
  • Invested Capital hit $18.3 million in Q4 2025 for STRATA Skin Sciences, up from $3.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $26.2 million in Q3 2021 to a low of $532000.0 in Q2 2025.
  • Historically, Invested Capital has averaged $15.8 million across 5 years, with a median of $17.6 million in 2023.
  • Biggest YoY gain for Invested Capital was 267.2% in 2025; the steepest drop was 94.4% in 2025.
  • Year by year, Invested Capital stood at $25.4 million in 2021, then fell by 14.1% to $21.8 million in 2022, then tumbled by 41.88% to $12.7 million in 2023, then tumbled by 60.81% to $5.0 million in 2024, then soared by 267.2% to $18.3 million in 2025.
  • Business Quant data shows Invested Capital for SSKN at $18.3 million in Q4 2025, $3.2 million in Q3 2025, and $532000.0 in Q2 2025.